Methods of treating cancer with anti-TIM-3 antibodies
US11926665B2 · kind B2 · utility
1Cited by
21References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 9, 2018 |
| Grant date | Mar 12, 2024 |
| Priority date | — |
| Expiry date | Feb 10, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/94
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides methods of administering certain TIM-3 binding agents to patients having cancer. Dosage regimens for compositions comprising a TIM-3 binding agent are also explicitly provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.